Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
TRS-2 PPMO Potential treatment - pre-clinical evidence Experimental Antiviral Nov/09/2020 1 0
TRS-1 PPMO Potential treatment - pre-clinical evidence Experimental Antiviral Nov/09/2020 1 0
Sorafenib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/09/2021 1 0
RQ3013-VLP Potential treatment - pre-clinical evidence Experimental Vaccine Aug/17/2020 1 0
repRNA-CoV2S Potential treatment - pre-clinical evidence Experimental Vaccine May/28/2020 1 0
REGN-COV2 Emergency use authorization Experimental Antiviral Mar/20/2021 1 0
NVX-CoV2373 Potential treatment - clinical evidence Experimental Vaccine Apr/07/2021 2 0
Nilotinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/09/2021 1 0
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/20/2021 1 0
N14-R7 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/07/2020 1 0